Cutler Group LP Idera Pharmaceuticals, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$0.41 - $0.7 $533 - $909	-1,300 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$0.53 - $1.03 $424 - $824	-800 Reduced 38.1%	1,300 $0
Q3 2021 Oct 26, 2021	SELL	$1.0 - $1.18 $3,000 - $3,540	-3,000 Reduced 58.82%	2,100 $2,000
Q2 2021 Jul 19, 2021	BUY	$1.01 - $1.58 $5,151 - $8,058	5,100 New	5,100 $6,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.